Efficacy and Safety of Perampanel as the First Medication for Children with Newly Diagnosed Epilepsy: A Real-World Single-Center Prospective Observational Study - Top-Institutions - MDSpire

Efficacy and Safety of Perampanel as the First Medication for Children with Newly Diagnosed Epilepsy: A Real-World Single-Center Prospective Observational Study

  • By

  • Huang, Wenmin

  • Cao, Dezhi

  • May 6, 2026

  • 0 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Shenzhen Children's Hospital
    Shenzhen Children's Hospital

    Shenzhen, Guangdong

    Key Differentiators

    • Pediatrics

  • #2

    Meyer Children’s Hospital of Florence
    Meyer Children’s Hospital of Florence

    Florence, Tuscany

    Key Differentiators

    • Pediatrics

  • #3

    Guy's Hospital Medical School
    Guy's Hospital Medical School

    London, England

    Key Differentiators

    • Pediatrics

  • #4

    Kenyan Medical Research Institute
    Kenyan Medical Research Institute

    Nairobi, Nairobi

    Key Differentiators

    • Pediatrics

Original Source(s)

Efficacy and Safety of Perampanel as the First Medication for Children with Newly Diagnosed Epilepsy: A Real-World Single-Center Prospective Observational Study

  • by Huang, Wenmin , Cao, Dezhi

  • May 6, 2026

Related Content

Perioperative anesthetic considerations and outcomes in Crouzon syndrome: a retrospective analysis of Le Fort III advancement surgery

Can Digital Tools Fix Bias in Mental Health Triage?

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.